| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | affects expression | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the expression of SLC6A9 mRNA | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:732097 | 6480464 | Ethinyl Estradiol results in increased expression of SLC6A9 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732097 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732097 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A9 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:732097 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC6A9 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC6A9 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:732097 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC6A9 mRNA | CTD | PMID:19933214 |
| 2-butoxyethanol | increases expression | ISO | RGD:732097 | 6480464 | n-butoxyethanol results in increased expression of SLC6A9 mRNA | CTD | PMID:19812364 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:732097 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC6A9 mRNA] | CTD | PMID:19467301 |
| aflatoxin B1 | increases expression | ISO | RGD:732097 | 6480464 | Aflatoxin B1 results in increased expression of SLC6A9 mRNA | CTD | PMID:19770486 |
| amphetamine | affects response to substance | ISO | RGD:732097 | 6480464 | SLC6A9 protein affects the susceptibility to Amphetamine | CTD | PMID:15159536 |
| benzo[a]pyrene | increases expression | ISO | RGD:732097 | 6480464 | Benzo(a)pyrene results in increased expression of SLC6A9 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:732096 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] results in increased expression of SLC6A9 mRNA | CTD | PMID:17690111 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732096 | 6480464 | Benzo(a)pyrene results in decreased expression of SLC6A9 mRNA | CTD | PMID:22316170 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:732097 | 6480464 | Mustard Gas results in decreased expression of SLC6A9 mRNA | CTD | PMID:15674843 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:732097 | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:732097 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SLC6A9 mRNA] | CTD | PMID:19850644 |
| choline | multiple interactions | ISO | RGD:732097 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:732097 | 6480464 | Ciguatoxins affects the expression of SLC6A9 mRNA | CTD | PMID:18353800 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of SLC6A9 mRNA | CTD | PMID:17602206 |
| coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of SLC6A9 mRNA | CTD | PMID:18480146 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:732097 | 6480464 | Tetrahydrocannabinol results in increased expression of SLC6A9 mRNA | CTD | PMID:21542829 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:732096 | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] results in increased expression of SLC6A9 mRNA | CTD | PMID:17690111 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of SLC6A9 mRNA | CTD | PMID:21266533 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA | CTD | PMID:18636392 |
| dioxygen | multiple interactions | ISO | RGD:732097 | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SLC6A9 mRNA] | CTD | PMID:22629407 |
| dioxygen | increases expression | ISO | RGD:732097 | 6480464 | Oxygen deficiency results in increased expression of SLC6A9 mRNA | CTD | PMID:22629407 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of SLC6A9 mRNA | CTD | PMID:21551480 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SLC6A9 mRNA | CTD | PMID:20655511 |
| folic acid | multiple interactions | ISO | RGD:732097 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene | CTD | PMID:20938992 |
| L-methionine | multiple interactions | ISO | RGD:732097 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC6A9 gene | CTD | PMID:20938992 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of SLC6A9 mRNA | CTD | PMID:11578147 |
| methamphetamine | increases response to substance | ISO | RGD:732096 | 6480464 | SLC6A9 gene SNP results in increased susceptibility to Methamphetamine | CTD | PMID:17582620 |
| methotrexate | affects expression | ISO | RGD:732097 | 6480464 | Methotrexate affects the expression of SLC6A9 mRNA | CTD | PMID:18502557 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:732097 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of SLC6A9 mRNA | CTD | PMID:22776087 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC6A9 mRNA | CTD | PMID:20360939 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of SLC6A9 mRNA | CTD | PMID:18636392 |
| paracetamol | affects expression | ISO | RGD:732097 | 6480464 | Acetaminophen affects the expression of SLC6A9 mRNA | CTD | PMID:17562736 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SLC6A9 mRNA | CTD | PMID:17077588 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SLC6A9 mRNA | CTD | PMID:17077588 PMID:18198484 |
| phenobarbital | multiple interactions | ISO | RGD:732097 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC6A9 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:732097 | 6480464 | Phenobarbital affects the expression of SLC6A9 mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | ISO | RGD:732097 | 6480464 | Phenobarbital results in increased expression of SLC6A9 mRNA | CTD | PMID:19482888 |
| phorone | affects expression | EXP | | 6480464 | phorone affects the expression of SLC6A9 mRNA | CTD | PMID:18198479 |
| pirinixic acid | increases expression | ISO | RGD:732097 | 6480464 | pirinixic acid results in increased expression of SLC6A9 mRNA | CTD | PMID:18301758 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SLC6A9 mRNA | CTD | PMID:19162173 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of SLC6A9 mRNA | CTD | PMID:15967596 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of SLC6A9 mRNA | CTD | PMID:18653662 |
| vanadium atom | decreases expression | ISO | RGD:732096 | 6480464 | Vanadium results in decreased expression of SLC6A9 mRNA | CTD | PMID:19000753 |
| vanadium(0) | decreases expression | ISO | RGD:732096 | 6480464 | Vanadium results in decreased expression of SLC6A9 mRNA | CTD | PMID:19000753 |